Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SUPRAX

CEFIXIME

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SUPRAX is listed in Drugs@FDA under application 065380 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFIXIME Form and strength TABLET, CHEWABLE;ORAL - 200MG Sponsor LUPIN LTD Submission history Latest submission status date: 2016-02-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview SUPRAX is listed in Drugs@FDA under application 065380 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFIXIME Form and strength TABLET, CHEWABLE;ORAL - 200MG Sponsor LUPIN LTD Submission history Latest submission status date: 2016-02-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.